September 25th 2023
Data from a 4-year trial of preschool-aged children offers new insight into the effects of initiating obesity management strategies among children in early life.
August 8th 2023
To combat this association, study investigators concluded a reduction in daily soft drink consumption should be a priority among school-going adolescents.
July 27th 2023
A new scientific statement indicates lifestyle interventions may change the trajectory of obesity-related cardiovascular risk from onset in childhood to manifestation in adulthood.
July 14th 2023
GLP-1 receptor agonists, used to treat diabetes, are now
also being used for obesity in children and adolescents.
July 7th 2023
An analysis of data from nearly 750,000 adolescents from more than 40 countries offers insight into the changing, and possibly inaccurate, perceptions of healthy body weight among younger people since the turn of the century.
AMA asking physicians to de-emphasize BMI use for health and obesity assessment
The American Medical Association is asking doctors to scale back the use of the body mass index (BMI) when assessing obesity and health in patients, noting it should be used jointly with other measurements, and not solely.
Imbalance in gut bacteria may play critical role in obesity development
A new analysis found differences in the gut bacteria seen in adults with obesity, suggesting that changes in the gut microbiota that predispose to adult obesity may begin in early childhood.
In utero exposure to COVID-19 may increase obesity risk in children
Children exposed to maternal COVID-19 during pregnancy showed lower birth weight, lower birth BMI, and accelerated postnatal weight gain, compared with those unexposed.
Improving built environments could help address adolescent obesity
Built environments, but not social and economic environments, were negatively associated with BMI and overweight or obesity status, with a stronger association among adolescents with longer exposure to their built environment.
Butyrate effective for treating pediatric obesity
In a recent study, reductions in body mass index along with further beneficial effects were found when using oral butyrate supplementation for treating pediatric obesity.
Treating pediatric obesity
In part 1 of our obesity series, Katherine H. Saunders, MD, DABOM, discusses methods of treating pediatric obesity, including medicines approved by the FDA and the advantages of Intellihealth.
School-based physical activity can curb childhood obesity rates
A study from Slovenia suggests a physical activity intervention that would require physical activity every day while at school was effective for reducing BMI and reversing obesity in young children.
Problems with alcohol increase after weight-loss surgery in adolescence
Youth who underwent metabolic and bariatric surgery as teenagers are at heightened risk for alcohol use, according to a recent study.
Sugary drinks tax may be effective in preventing childhood obesity
A sugary drinks tax in England may have prevented over 5,000 cases of obesity a year in older girls, but had no significant association with obesity levels in year six boys or younger children.
Gardening interventions improve metabolic parameters in youth
A follow-up to a Texas Sprouts gardening intervention found improved glucose control and reduced low-density lipoprotein cholesterol in individuals at a high risk of metabolic diseases.
AAP releases guideline on evaluating and treating pediatric obesity
The February 2023 edition of Pediatrics included evidence-based guidelines from the American Academy of Pediatrics on evaluating and treating obesity in children and adolescents.
Better neighborhood conditions lower obesity risk in youth
A recent study found that children were more likely to present with high BMI and obesity if they had low Child Opportunity Index scores early in life.
Study raises concerns over increasing BMI, obesity in preschool-aged children during pandemic
Using data from more than 25,000 preschool-aged children in Sweden provides an overview in trends of weight gain and BMI changes that may have impacted pediatric populations during the COVID-19 pandemic.
Obesity in children with medical complexity
In a recent study, it was found that children with medical complexity are at a greater risk of overweight and obesity compared to children without medical complexity.
FDA approves semaglutide for obesity in adolescents
Novo Nordisk has announced their product Wegovy received approval from the US Food and Drug Administration for use in adolescents aged 12 years and older with obesity.
Prevalence of obesity in pediatric type 2 diabetes
In a recent study, it was found that obesity is not present in all cases of type 2 diabetes in pediatric patients.
Pediatric obesity presents complexities in medication dosing
Amy L. Kiskaddon, PharmD, MBA, BCPPS, discusses how medication doses need to be adjusted for pediatric patients with obesity.
Gut health supplements may treat pediatric obesity
In a recent trial, pediatric patients taking butyrate supplements more often saw a significant reduction in body mass index than those taking placebo.
Semaglutide reduces BMI in obese adolescents
In a recent study, adolescents, who received weekly doses of semaglutide 2.4 mg alongside lifestyle intervention, saw a significantly greater reduction in body mass index by week 68 than those only given lifestyle intervention.
Telemedicine intervention effective against childhood obesity
At the American Academy of Pediatrics National Conference & Exhibition, Cassandra Padgett, MS, ACE health coach, discussed how telemedicine intervention effectively managed obesity in pediatric patients during the COVID-19 pandemic.
Maternal obesity and excessive weight gain increase ADHD risk in offspring
A recent study independently associated maternal obesity with ADHD risk in offspring, with a significant risk observed in joint obesity and excessive weight gain.
Exercise improves brain outcomes in overweight or obese children
The ActiveBrains trials associated exercise with improved intelligence and cognitive function in overweight or obese children.
Pediatric obesity: A bigger problem than we thought
Dr. Gregory Weiss reflects on a recent literature review breaking down different subtypes of pediatric obesity.
How to engage in effective clinical conversations about obesity
Small shifts in your communication style and tactics when discussing obesity with patients can significantly impact how your message is received.
QSYMIA approved by FDA for treatment of obesity in adolescents
VIVUS LLC announced the US Food and Drug Administration's approval of QSYMIA (phentermine and topiramate extended-release capsules) for the treatment of obesity in adolescents ages 12 to 17 years.
Do infant weight gain patterns affect adult risk of coronary heart disease?
Based on an investigation of associations between patterns of growth in infant weight and adult-onset coronary heart disease, the answer seems to be no.
FDA approves treatment for chronic weight management in adolescents aged 12 years and older
Recently, the FDA announced the approval of supplemental indication for phentermine and topiramate extended-release capsules for chronic weight management in children aged 12 years and older.
Obesity in pediatrics: perspectives from a pediatrician and a pediatric nurse practitioner
Two pediatric health care providers offer best practices for treating patients with obesity.
Managing pandemic related obesity in schools
School nurses and nurse practitioners play an important role in assessing the child’s health status related to obesity, potential for co-morbidities, and implementing appropriate management strategies.
Obesity in children and the impact of COVID-19
As we begin to emerge from the national lockdown due to the COVID-19 pandemic, many pediatricians may find that the already widespread problem of youth-onset obesity is worse than ever.
2 Clarke Drive Cranbury, NJ 08512